O	O	O	0	8	Monocyte	Monocyte	B-NP	NN	O	2	NMOD	O
O	O	O	9	15	arrest	arrest	I-NP	NN	O	4	NMOD	O
O	O	O	16	19	and	and	I-NP	CC	O	4	NMOD	O
O	O	O	20	34	transmigration	transmigration	I-NP	NN	O	11	SUB	O
O	O	O	35	37	on	on	B-PP	IN	O	4	NMOD	O
O	O	O	38	46	inflamed	inflamed	B-NP	JJ	O	7	NMOD	O
O	O	O	47	58	endothelium	endothelium	I-NP	NN	O	5	PMOD	O
O	O	O	59	61	in	in	B-PP	IN	O	4	NMOD	O
O	O	O	62	67	shear	shear	B-NP	NN	O	10	NMOD	O
O	O	O	68	72	flow	flow	I-NP	NN	O	8	PMOD	O
O	O	O	73	75	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	76	85	inhibited	inhibit	I-VP	VBN	O	11	VC	O
O	O	O	86	88	by	by	B-PP	IN	O	12	VMOD	O
O	O	O	89	99	adenovirus	adenovirus	B-NP	NN	O	18	NMOD	O
O	O	O	99	100	-	-	B-NP	HYPH	O	18	NMOD	O
O	O	O	100	108	mediated	mediate	I-NP	VBN	O	18	NMOD	O
O	O	O	109	113	gene	gene	I-NP	NN	O	18	NMOD	O
O	O	O	114	122	transfer	transfer	I-NP	NN	O	13	PMOD	O
O	O	O	123	125	of	of	B-PP	IN	O	18	NMOD	O
T1	B-Protein	B-Protein	126	133	IkappaB	IkappaB	B-NP	NN	B-protein	22	NMOD	B-protein
T1	I-Protein	I-Protein	133	134	-	-	O	HYPH	O	22	P	O
T1	I-Protein	I-Protein	134	139	alpha	alpha	B-NP	SYM	O	19	PMOD	O
O	O	O	139	140	.	.	O	.	O	11	P	O

O	O	O	142	154	Mobilization	Mobilization	B-NP	NN	O	12	SUB	O
O	O	O	155	157	of	of	B-PP	IN	O	1	NMOD	O
T25	B-Entity	B-Entity	158	165	nuclear	nuclear	B-NP	JJ	B-protein	6	NMOD	B-protein
T25	I-Entity	I-Entity	166	172	factor	factor	I-NP	NN	I-protein	6	NMOD	I-protein
T25	I-Entity	I-Entity	172	173	-	-	O	HYPH	I-protein	6	P	I-protein
T25	I-Entity	I-Entity	173	179	kappaB	kappaB	B-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	180	181	(	(	O	(	O	11	DEP	O
T26	B-Entity	B-Entity	181	183	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
T26	I-Entity	I-Entity	183	184	-	-	B-NP	HYPH	I-protein	10	P	I-protein
T26	I-Entity	I-Entity	184	190	kappaB	kappaB	I-NP	NN	I-protein	11	DEP	I-protein
O	O	O	190	191	)	)	O	)	O	6	NMOD	O
O	O	O	192	201	activates	activate	B-VP	VBZ	O	0	ROOT	O
O	O	O	202	215	transcription	transcription	B-NP	NN	O	12	OBJ	O
O	O	O	216	218	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	219	224	genes	gene	B-NP	NNS	B-DNA	14	PMOD	B-DNA
O	O	O	225	233	encoding	encode	B-VP	VBG	O	15	NMOD	O
O	O	O	234	245	endothelial	endothelial	B-NP	JJ	B-protein	19	NMOD	B-protein
O	O	O	246	254	adhesion	adhesion	I-NP	NN	I-protein	19	NMOD	I-protein
O	O	O	255	264	molecules	molecule	I-NP	NNS	I-protein	21	NMOD	I-protein
O	O	O	265	268	and	and	I-NP	CC	O	21	NMOD	O
O	O	O	269	279	chemokines	chemokine	I-NP	NNS	B-protein	16	OBJ	B-protein
O	O	O	280	284	that	that	B-NP	WDT	O	15	NMOD	O
O	O	O	285	295	contribute	contribute	B-VP	VBP	O	22	SBAR	O
O	O	O	296	298	to	to	B-PP	TO	O	23	VMOD	O
O	O	O	299	307	monocyte	monocyte	B-NP	NN	O	26	NMOD	O
O	O	O	308	320	infiltration	infiltration	I-NP	NN	O	24	PMOD	O
O	O	O	321	329	critical	critical	B-ADJP	JJ	O	26	NMOD	O
O	O	O	330	332	in	in	B-PP	IN	O	27	AMOD	O
O	O	O	333	346	atherogenesis	atherogenesis	B-NP	NN	O	28	PMOD	O
O	O	O	346	347	.	.	O	.	O	12	P	O

O	O	O	348	358	Inhibition	Inhibition	B-NP	NN	O	6	SUB	O
O	O	O	359	361	of	of	B-PP	IN	O	1	NMOD	O
T27	B-Entity	B-Entity	362	364	NF	NF	B-NP	NN	B-protein	5	NMOD	B-protein
T27	I-Entity	I-Entity	364	365	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T27	I-Entity	I-Entity	365	371	kappaB	kappaB	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	372	375	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	O	376	380	been	be	I-VP	VBN	O	6	VC	O
O	O	O	381	389	achieved	achieve	I-VP	VBN	O	7	VC	O
O	O	O	390	392	by	by	B-PP	IN	O	8	VMOD	O
O	O	O	393	408	pharmacological	pharmacological	B-NP	JJ	O	12	AMOD	O
O	O	O	409	412	and	and	I-NP	CC	O	12	AMOD	O
O	O	O	413	420	genetic	genetic	I-NP	JJ	O	13	NMOD	O
O	O	O	421	431	approaches	approach	I-NP	NNS	O	9	PMOD	O
O	O	O	431	432	;	;	O	:	O	6	VMOD	O
O	O	O	433	440	however	however	B-ADVP	RB	O	14	ROOT	O
O	O	O	440	441	,	,	O	,	O	15	AMOD	O
O	O	O	442	450	monocyte	monocyte	B-NP	NN	O	18	NMOD	O
O	O	O	451	463	interactions	interaction	I-NP	NNS	O	16	ROOT	O
O	O	O	464	468	with	with	B-PP	IN	O	18	NMOD	O
O	O	O	469	478	activated	activate	B-NP	VBN	O	21	NMOD	O
O	O	O	479	490	endothelium	endothelium	I-NP	NN	O	19	PMOD	O
O	O	O	491	493	in	in	B-PP	IN	O	18	NMOD	O
O	O	O	494	499	shear	shear	B-NP	NN	O	24	NMOD	O
O	O	O	500	504	flow	flow	I-NP	NN	O	22	PMOD	O
O	O	O	505	514	following	follow	B-PP	VBG	O	24	NMOD	O
O	O	O	515	519	gene	gene	B-NP	NN	O	27	NMOD	O
O	O	O	520	528	transfer	transfer	I-NP	NN	O	25	PMOD	O
O	O	O	529	531	of	of	B-PP	IN	O	27	NMOD	O
O	O	O	532	535	the	the	B-NP	DT	O	33	NMOD	O
T28	B-Entity	B-Entity	536	538	NF	NF	I-NP	NN	B-protein	32	NMOD	B-protein
T28	I-Entity	I-Entity	538	539	-	-	B-NP	HYPH	I-protein	32	NMOD	I-protein
T28	I-Entity	I-Entity	539	545	kappaB	kappaB	I-NP	NN	I-protein	33	NMOD	I-protein
O	O	O	546	555	inhibitor	inhibitor	I-NP	NN	O	37	SUB	O
T2	B-Protein	B-Protein	556	563	IkappaB	IkappaB	I-NP	NN	B-protein	36	NMOD	B-protein
T2	I-Protein	I-Protein	563	564	-	-	O	HYPH	O	36	P	O
T2	I-Protein	I-Protein	564	569	alpha	alpha	B-NP	SYM	O	37	P	O
O	O	O	570	574	have	have	B-VP	VBP	O	28	SBAR	O
O	O	O	575	578	not	not	I-VP	RB	O	37	VMOD	O
O	O	O	579	583	been	be	I-VP	VBN	O	37	VC	O
O	O	O	584	591	studied	study	I-VP	VBN	O	39	VC	O
O	O	O	591	592	.	.	O	.	O	18	P	O

O	O	O	593	595	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	596	601	found	find	B-VP	VBD	O	0	ROOT	O
O	O	O	602	606	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	607	621	overexpression	overexpression	B-NP	NN	O	16	SUB	O
O	O	O	622	624	of	of	B-PP	IN	O	4	NMOD	O
T3	B-Protein	B-Protein	625	632	IkappaB	IkappaB	B-NP	NN	B-protein	8	NMOD	B-protein
T3	I-Protein	I-Protein	632	633	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T3	I-Protein	I-Protein	633	638	alpha	alpha	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	O	639	641	in	in	B-PP	IN	O	4	NMOD	O
O	O	O	642	653	endothelial	endothelial	B-NP	JJ	B-cell_type	11	NMOD	B-cell_type
O	O	O	654	659	cells	cell	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	O	660	665	using	use	B-VP	VBG	O	4	NMOD	O
O	O	O	666	667	a	a	B-NP	DT	O	15	NMOD	O
O	O	O	668	679	recombinant	recombinant	I-NP	JJ	O	15	NMOD	O
O	O	O	680	690	adenovirus	adenovirus	I-NP	NN	O	12	OBJ	O
O	O	O	691	700	prevented	prevent	B-VP	VBD	O	3	SBAR	O
T4	B-Protein	B-Protein	701	706	tumor	tumor	B-NP	NN	B-protein	21	NMOD	B-protein
T4	I-Protein	I-Protein	707	715	necrosis	necrosis	I-NP	NN	I-protein	21	NMOD	I-protein
T4	I-Protein	I-Protein	716	722	factor	factor	I-NP	NN	I-protein	21	NMOD	I-protein
T4	I-Protein	I-Protein	722	723	-	-	O	HYPH	I-protein	21	P	I-protein
T4	I-Protein	I-Protein	723	728	alpha	alpha	B-NP	SYM	I-protein	25	NMOD	I-protein
O	O	O	729	730	(	(	O	(	O	25	NMOD	O
T5	B-Protein	B-Protein	730	733	TNF	TNF	B-NP	NN	B-protein	25	NMOD	B-protein
T5	I-Protein	I-Protein	733	734	-	-	O	HYPH	O	25	P	O
T5	I-Protein	I-Protein	734	739	alpha	alpha	B-NP	SYM	O	29	NMOD	O
O	O	O	739	740	)	)	O	)	O	25	AMOD	O
O	O	O	740	741	-	-	B-NP	HYPH	O	25	P	O
O	O	O	741	748	induced	induce	I-NP	VBN	O	29	NMOD	O
O	O	O	749	760	degradation	degradation	I-NP	NN	O	16	OBJ	O
O	O	O	761	763	of	of	B-PP	IN	O	29	NMOD	O
T6	B-Protein	B-Protein	764	771	IkappaB	IkappaB	B-NP	NN	B-protein	33	NMOD	B-protein
T6	I-Protein	I-Protein	771	772	-	-	O	HYPH	O	33	P	O
T6	I-Protein	I-Protein	772	777	alpha	alpha	B-NP	SYM	O	30	PMOD	O
O	O	O	778	781	and	and	O	CC	O	16	VMOD	O
O	O	O	782	792	suppressed	suppress	B-VP	VBD	O	16	VMOD	O
O	O	O	793	796	the	the	B-NP	DT	O	37	NMOD	O
O	O	O	797	809	upregulation	upregulation	I-NP	NN	O	35	OBJ	O
O	O	O	810	812	of	of	B-PP	IN	O	37	NMOD	O
T7	B-Protein	B-Protein	813	821	vascular	vascular	B-NP	JJ	B-protein	42	NMOD	B-protein
T7	I-Protein	I-Protein	822	826	cell	cell	I-NP	NN	I-protein	42	NMOD	I-protein
T7	I-Protein	I-Protein	827	835	adhesion	adhesion	I-NP	NN	I-protein	42	NMOD	I-protein
T7	I-Protein	I-Protein	836	844	molecule	molecule	I-NP	NN	I-protein	44	NMOD	I-protein
T7	I-Protein	I-Protein	844	845	-	-	B-NP	HYPH	O	44	P	O
T7	I-Protein	I-Protein	845	846	1	1	I-NP	CD	O	53	NMOD	O
O	O	O	847	848	(	(	O	(	O	49	DEP	O
T8	B-Protein	B-Protein	848	852	VCAM	VCAM	B-NP	NN	B-protein	47	NMOD	B-protein
T8	I-Protein	I-Protein	852	853	-	-	B-NP	HYPH	I-protein	49	DEP	I-protein
T8	I-Protein	I-Protein	853	854	1	1	I-NP	CD	I-protein	47	NMOD	I-protein
O	O	O	854	855	)	)	O	)	O	44	NMOD	O
O	O	O	855	856	,	,	O	,	O	53	P	O
T9	B-Protein	B-Protein	857	870	intercellular	intercellular	B-NP	JJ	B-protein	53	NMOD	B-protein
T9	I-Protein	I-Protein	871	879	adhesion	adhesion	I-NP	NN	I-protein	53	NMOD	I-protein
T9	I-Protein	I-Protein	880	888	molecule	molecule	I-NP	NN	I-protein	70	NMOD	I-protein
T9	I-Protein	I-Protein	888	889	-	-	B-NP	HYPH	O	55	P	O
T9	I-Protein	I-Protein	889	890	1	1	I-NP	CD	O	53	NMOD	O
O	O	O	891	892	(	(	O	(	O	60	DEP	O
T10	B-Protein	B-Protein	892	896	ICAM	ICAM	B-NP	NN	B-protein	58	NMOD	B-protein
T10	I-Protein	I-Protein	896	897	-	-	B-NP	HYPH	I-protein	60	DEP	I-protein
T10	I-Protein	I-Protein	897	898	1	1	I-NP	CD	I-protein	58	NMOD	I-protein
O	O	O	898	899	)	)	O	)	O	53	NMOD	O
O	O	O	899	900	,	,	O	,	O	70	P	O
O	O	O	901	904	and	and	O	CC	O	70	NMOD	O
T11	B-Protein	B-Protein	905	906	E	E	B-NP	NN	B-RNA	66	NMOD	B-RNA
T11	I-Protein	I-Protein	906	907	-	-	O	HYPH	I-RNA	66	NMOD	I-RNA
T11	I-Protein	I-Protein	907	915	selectin	selectin	B-NP	NN	I-RNA	66	NMOD	I-RNA
O	O	O	916	920	mRNA	mRNA	I-NP	NN	I-RNA	70	NMOD	I-RNA
O	O	O	921	924	and	and	O	CC	O	70	NMOD	O
O	O	O	925	932	surface	surface	B-NP	NN	O	70	NMOD	O
O	O	O	933	940	protein	protein	I-NP	NN	O	70	NMOD	O
O	O	O	941	951	expression	expression	I-NP	NN	O	73	NMOD	O
O	O	O	952	955	and	and	O	CC	O	73	NMOD	O
O	O	O	956	959	the	the	B-NP	DT	O	73	NMOD	O
O	O	O	960	972	upregulation	upregulation	I-NP	NN	O	38	PMOD	O
O	O	O	973	975	of	of	B-PP	IN	O	73	NMOD	O
O	O	O	976	987	transcripts	transcript	B-NP	NNS	O	74	PMOD	O
O	O	O	988	991	for	for	B-PP	IN	O	75	NMOD	O
O	O	O	992	995	the	the	B-NP	DT	O	81	NMOD	O
O	O	O	996	1006	chemokines	chemokine	I-NP	NNS	B-protein	81	NMOD	B-protein
T12	B-Protein	B-Protein	1007	1015	monocyte	monocyte	I-NP	NN	B-protein	81	NMOD	B-protein
T12	I-Protein	I-Protein	1016	1031	chemoattractant	chemoattractant	I-NP	NN	I-protein	81	NMOD	I-protein
T12	I-Protein	I-Protein	1032	1039	protein	protein	I-NP	NN	I-protein	94	NMOD	I-protein
T12	I-Protein	I-Protein	1040	1041	1	1	I-NP	CD	I-protein	81	NMOD	I-protein
O	O	O	1042	1043	(	(	O	(	O	87	DEP	O
T13	B-Protein	B-Protein	1043	1046	MCP	MCP	B-NP	NN	B-protein	85	NMOD	B-protein
T13	I-Protein	I-Protein	1046	1047	-	-	B-NP	HYPH	I-protein	87	DEP	I-protein
T13	I-Protein	I-Protein	1047	1048	1	1	I-NP	CD	I-protein	85	NMOD	I-protein
O	O	O	1048	1049	)	)	O	)	O	81	NMOD	O
O	O	O	1050	1053	and	and	O	CC	O	94	NMOD	O
T14	B-Protein	B-Protein	1054	1060	growth	growth	B-NP	NN	B-protein	94	NMOD	B-protein
T14	I-Protein	I-Protein	1060	1061	-	-	O	HYPH	I-protein	94	P	I-protein
T14	I-Protein	I-Protein	1061	1068	related	relate	B-NP	VBN	I-protein	92	NMOD	I-protein
T14	I-Protein	I-Protein	1069	1077	activity	activity	I-NP	NN	I-protein	94	NMOD	I-protein
T14	I-Protein	I-Protein	1077	1078	-	-	O	HYPH	I-protein	94	P	I-protein
T14	I-Protein	I-Protein	1078	1083	alpha	alpha	B-NP	SYM	I-protein	76	PMOD	I-protein
O	O	O	1084	1085	(	(	O	(	O	99	DEP	O
T15	B-Protein	B-Protein	1085	1088	GRO	GRO	B-NP	NN	B-protein	98	NMOD	B-protein
T15	I-Protein	I-Protein	1088	1089	-	-	B-NP	HYPH	I-protein	98	P	I-protein
T15	I-Protein	I-Protein	1089	1094	alpha	alpha	I-NP	NN	I-protein	99	DEP	I-protein
O	O	O	1094	1095	)	)	O	)	O	94	NMOD	O
O	O	O	1096	1098	by	by	B-PP	IN	O	73	NMOD	O
T16	B-Protein	B-Protein	1099	1102	TNF	TNF	B-NP	NN	B-protein	103	NMOD	B-protein
T16	I-Protein	I-Protein	1102	1103	-	-	O	HYPH	O	103	P	O
T16	I-Protein	I-Protein	1103	1108	alpha	alpha	B-NP	SYM	O	100	PMOD	O
O	O	O	1108	1109	.	.	O	.	O	2	P	O

O	O	O	1110	1114	This	This	B-NP	DT	O	2	SUB	O
O	O	O	1115	1118	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1119	1129	associated	associate	I-VP	VBN	O	2	VC	O
O	O	O	1130	1134	with	with	B-PP	IN	O	3	VMOD	O
O	O	O	1135	1136	a	a	B-NP	DT	O	6	NMOD	O
O	O	O	1137	1146	reduction	reduction	I-NP	NN	O	4	PMOD	O
O	O	O	1147	1149	in	in	B-PP	IN	O	6	NMOD	O
O	O	O	1150	1161	endothelial	endothelial	B-NP	JJ	O	12	NMOD	O
T17	B-Protein	B-Protein	1162	1165	MCP	MCP	I-NP	NN	B-protein	12	NMOD	B-protein
T17	I-Protein	I-Protein	1165	1166	-	-	B-NP	HYPH	I-protein	12	NMOD	I-protein
T17	I-Protein	I-Protein	1166	1167	1	1	I-NP	CD	I-protein	12	NMOD	I-protein
O	O	O	1168	1177	secretion	secretion	I-NP	NN	O	17	NMOD	O
O	O	O	1178	1181	and	and	I-NP	CC	O	17	NMOD	O
T18	B-Protein	B-Protein	1182	1185	GRO	GRO	I-NP	NN	B-protein	17	NMOD	B-protein
T18	I-Protein	I-Protein	1185	1186	-	-	O	HYPH	O	17	NMOD	O
T18	I-Protein	I-Protein	1186	1191	alpha	alpha	B-NP	SYM	O	17	NMOD	O
O	O	O	1192	1206	immobilization	immobilization	I-NP	NN	O	7	PMOD	O
O	O	O	1206	1207	.	.	O	.	O	2	P	O

O	O	O	1208	1216	Adhesion	Adhesion	B-NP	NN	O	2	NMOD	O
O	O	O	1217	1223	assays	assay	I-NP	NNS	O	8	SUB	O
O	O	O	1224	1229	under	under	B-PP	IN	O	2	NMOD	O
O	O	O	1230	1243	physiological	physiological	B-NP	JJ	O	7	NMOD	O
O	O	O	1244	1249	shear	shear	I-NP	NN	O	7	NMOD	O
O	O	O	1250	1254	flow	flow	I-NP	NN	O	7	NMOD	O
O	O	O	1255	1265	conditions	condition	I-NP	NNS	O	3	PMOD	O
O	O	O	1266	1272	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	1273	1277	that	that	B-SBAR	IN	O	8	VMOD	O
O	O	O	1278	1282	firm	firm	B-NP	JJ	O	11	NMOD	O
O	O	O	1283	1289	arrest	arrest	I-NP	NN	O	16	NMOD	O
O	O	O	1289	1290	,	,	O	,	O	16	P	O
O	O	O	1291	1300	spreading	spreading	B-NP	NN	O	16	NMOD	O
O	O	O	1300	1301	,	,	O	,	O	16	P	O
O	O	O	1302	1305	and	and	O	CC	O	16	NMOD	O
O	O	O	1306	1320	transmigration	transmigration	B-NP	NN	O	26	SUB	O
O	O	O	1321	1323	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1324	1333	monocytes	monocyte	B-NP	NNS	B-cell_type	17	PMOD	B-cell_type
O	O	O	1334	1336	on	on	B-PP	IN	O	16	NMOD	O
T19	B-Protein	B-Protein	1337	1340	TNF	TNF	B-NP	NN	B-protein	22	NMOD	B-protein
T19	I-Protein	I-Protein	1340	1341	-	-	O	HYPH	O	22	P	O
T19	I-Protein	I-Protein	1341	1346	alpha	alpha	O	SYM	O	25	NMOD	O
O	O	O	1346	1347	-	-	O	HYPH	O	25	NMOD	O
O	O	O	1347	1356	activated	activate	B-NP	VBN	O	25	NMOD	O
O	O	O	1357	1368	endothelium	endothelium	I-NP	NN	O	19	PMOD	O
O	O	O	1369	1372	was	be	B-VP	VBD	O	9	SBAR	O
O	O	O	1373	1381	markedly	markedly	I-VP	RB	O	26	VMOD	O
O	O	O	1382	1391	inhibited	inhibit	I-VP	VBN	O	26	VC	O
O	O	O	1392	1394	by	by	B-PP	IN	O	28	VMOD	O
T20	B-Protein	B-Protein	1395	1402	IkappaB	IkappaB	B-NP	NN	B-protein	33	NMOD	B-protein
T20	I-Protein	I-Protein	1402	1403	-	-	O	HYPH	O	33	NMOD	O
T20	I-Protein	I-Protein	1403	1408	alpha	alpha	B-NP	SYM	O	33	NMOD	O
O	O	O	1409	1423	overexpression	overexpression	I-NP	NN	O	29	PMOD	O
O	O	O	1423	1424	.	.	O	.	O	8	P	O

O	O	O	1425	1435	Inhibition	Inhibition	B-NP	NN	O	8	SUB	O
O	O	O	1436	1440	with	with	B-PP	IN	O	1	NMOD	O
O	O	O	1441	1451	monoclonal	monoclonal	B-NP	JJ	B-protein	4	NMOD	B-protein
O	O	O	1452	1462	antibodies	antibody	I-NP	NNS	I-protein	7	NMOD	I-protein
O	O	O	1463	1466	and	and	O	CC	O	7	NMOD	O
T29	B-Entity	B-Entity	1467	1474	peptide	peptide	B-NP	NN	O	7	NMOD	O
T29	I-Entity	I-Entity	1475	1486	antagonists	antagonist	I-NP	NNS	O	2	PMOD	O
O	O	O	1487	1495	inferred	infer	B-VP	VBD	O	0	ROOT	O
O	O	O	1496	1500	that	that	B-SBAR	IN	O	8	VMOD	O
O	O	O	1501	1505	this	this	B-NP	DT	O	11	SUB	O
O	O	O	1506	1509	was	be	B-VP	VBD	O	9	SBAR	O
O	O	O	1510	1513	due	due	B-ADJP	JJ	O	11	PRD	O
O	O	O	1514	1516	to	to	B-PP	TO	O	12	AMOD	O
O	O	O	1517	1524	reduced	reduce	B-NP	VBN	O	15	NMOD	O
O	O	O	1525	1535	expression	expression	I-NP	NN	O	13	PMOD	O
O	O	O	1536	1538	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	1539	1541	Ig	Ig	B-NP	NN	O	19	NMOD	O
O	O	O	1542	1550	integrin	integrin	I-NP	NN	O	19	NMOD	O
O	O	O	1551	1557	ligand	ligand	I-NP	NN	O	16	PMOD	O
O	O	O	1558	1560	as	as	B-CONJP	RB	O	15	NMOD	O
O	O	O	1561	1565	well	well	I-CONJP	RB	O	20	DEP	O
O	O	O	1566	1568	as	as	I-CONJP	IN	O	20	DEP	O
O	O	O	1569	1571	of	of	B-PP	IN	O	20	PMOD	O
O	O	O	1572	1582	chemokines	chemokine	B-NP	NNS	B-protein	23	PMOD	B-protein
O	O	O	1583	1595	specifically	specifically	B-VP	RB	O	26	VMOD	O
O	O	O	1596	1604	involved	involve	I-VP	VBN	O	24	NMOD	O
O	O	O	1605	1607	in	in	B-PP	IN	O	26	VMOD	O
O	O	O	1608	1613	these	these	B-NP	DT	O	29	NMOD	O
O	O	O	1614	1620	events	event	I-NP	NNS	O	27	PMOD	O
O	O	O	1620	1621	.	.	O	.	O	8	P	O

O	O	O	1622	1624	In	In	B-PP	IN	O	7	VMOD	O
O	O	O	1625	1633	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	O	1633	1634	,	,	O	,	O	7	P	O
O	O	O	1635	1642	rolling	rolling	B-NP	NN	O	7	SUB	O
O	O	O	1643	1645	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	1646	1655	monocytes	monocyte	B-NP	NNS	B-cell_type	5	PMOD	B-cell_type
O	O	O	1656	1659	was	be	B-VP	VBD	O	26	VMOD	O
O	O	O	1660	1669	increased	increase	I-VP	VBN	O	7	VC	O
O	O	O	1670	1672	by	by	B-PP	IN	O	8	VMOD	O
T21	B-Protein	B-Protein	1673	1680	IkappaB	IkappaB	B-NP	NN	B-protein	13	NMOD	B-protein
T21	I-Protein	I-Protein	1680	1681	-	-	O	HYPH	O	13	NMOD	O
T21	I-Protein	I-Protein	1681	1686	alpha	alpha	O	SYM	O	13	NMOD	O
O	O	O	1687	1695	transfer	transfer	B-NP	NN	O	9	PMOD	O
O	O	O	1696	1699	and	and	O	CC	O	7	VMOD	O
O	O	O	1700	1703	was	be	B-VP	VBD	O	7	VMOD	O
O	O	O	1704	1710	partly	partly	I-VP	RB	O	15	VMOD	O
O	O	O	1711	1719	mediated	mediate	I-VP	VBN	O	15	VC	O
O	O	O	1720	1722	by	by	B-PP	IN	O	17	VMOD	O
T22	B-Protein	B-Protein	1723	1724	P	P	B-NP	NN	B-protein	21	NMOD	B-protein
T22	I-Protein	I-Protein	1724	1725	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T22	I-Protein	I-Protein	1725	1733	selectin	selectin	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	O	1733	1734	;	;	O	:	O	26	P	O
O	O	O	1735	1742	however	however	B-ADVP	RB	O	26	VMOD	O
O	O	O	1742	1743	,	,	O	,	O	26	P	O
O	O	O	1744	1746	it	it	B-NP	PRP	O	26	SUB	O
O	O	O	1747	1755	appeared	appear	B-VP	VBD	O	0	ROOT	O
O	O	O	1756	1758	to	to	I-VP	TO	O	28	VMOD	O
O	O	O	1759	1761	be	be	I-VP	VB	O	26	VMOD	O
O	O	O	1762	1772	unaffected	unaffected	B-ADJP	JJ	O	28	VC	O
O	O	O	1773	1775	by	by	B-PP	IN	O	29	VMOD	O
O	O	O	1776	1779	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	1780	1790	inhibition	inhibition	I-NP	NN	O	30	PMOD	O
O	O	O	1791	1793	of	of	B-PP	IN	O	32	NMOD	O
T23	B-Protein	B-Protein	1794	1795	E	E	B-NP	NN	B-protein	37	NMOD	B-protein
T23	I-Protein	I-Protein	1795	1796	-	-	B-NP	HYPH	I-protein	37	NMOD	I-protein
T23	I-Protein	I-Protein	1796	1804	selectin	selectin	I-NP	NN	I-protein	37	NMOD	I-protein
O	O	O	1805	1814	induction	induction	I-NP	NN	O	33	PMOD	O
O	O	O	1814	1815	.	.	O	.	O	26	P	O

O	O	O	1816	1820	Thus	Thus	B-ADVP	RB	O	5	VMOD	O
O	O	O	1820	1821	,	,	O	,	O	5	P	O
O	O	O	1822	1825	our	our	B-NP	PRP$	O	4	NMOD	O
O	O	O	1826	1830	data	datum	I-NP	NNS	O	5	SUB	O
O	O	O	1831	1838	provide	provide	B-VP	VBP	O	0	ROOT	O
O	O	O	1839	1844	novel	novel	B-NP	JJ	O	7	NMOD	O
O	O	O	1845	1853	evidence	evidence	I-NP	NN	O	5	OBJ	O
O	O	O	1854	1858	that	that	B-SBAR	IN	O	7	NMOD	O
O	O	O	1859	1868	selective	selective	B-NP	JJ	O	10	NMOD	O
O	O	O	1869	1879	modulation	modulation	I-NP	NN	O	22	SUB	O
O	O	O	1880	1882	of	of	B-PP	IN	O	10	NMOD	O
T30	B-Entity	B-Entity	1883	1885	NF	NF	B-NP	NN	B-protein	14	NMOD	B-protein
T30	I-Entity	I-Entity	1885	1886	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T30	I-Entity	I-Entity	1886	1892	kappaB	kappaB	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	O	1893	1895	by	by	B-PP	IN	O	10	NMOD	O
O	O	O	1896	1906	adenoviral	adenoviral	B-NP	JJ	O	17	NMOD	O
O	O	O	1907	1915	transfer	transfer	I-NP	NN	O	15	PMOD	O
O	O	O	1916	1918	of	of	B-PP	IN	O	17	NMOD	O
T24	B-Protein	B-Protein	1919	1926	IkappaB	IkappaB	B-NP	NN	B-protein	21	NMOD	B-protein
T24	I-Protein	I-Protein	1926	1927	-	-	O	HYPH	O	21	P	O
T24	I-Protein	I-Protein	1927	1932	alpha	alpha	B-NP	SYM	O	18	PMOD	O
O	O	O	1933	1940	impairs	impair	B-VP	VBZ	O	8	SBAR	O
O	O	O	1941	1944	the	the	B-NP	DT	O	24	NMOD	O
O	O	O	1945	1955	expression	expression	I-NP	NN	O	22	OBJ	O
O	O	O	1956	1958	of	of	B-PP	IN	O	24	NMOD	O
O	O	O	1959	1967	multiple	multiple	B-NP	JJ	O	29	NMOD	O
O	O	O	1968	1979	endothelial	endothelial	I-NP	JJ	B-protein	29	NMOD	B-protein
O	O	O	1980	1984	gene	gene	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	O	1985	1993	products	product	I-NP	NNS	I-protein	25	PMOD	I-protein
O	O	O	1994	2002	required	require	B-VP	VBN	O	29	NMOD	O
O	O	O	2003	2006	for	for	B-PP	IN	O	30	VMOD	O
O	O	O	2007	2017	subsequent	subsequent	B-NP	JJ	O	34	NMOD	O
O	O	O	2018	2026	monocyte	monocyte	I-NP	NN	O	34	NMOD	O
O	O	O	2027	2033	arrest	arrest	I-NP	NN	O	36	NMOD	O
O	O	O	2034	2037	and	and	I-NP	CC	O	36	NMOD	O
O	O	O	2038	2048	emigration	emigration	I-NP	NN	O	31	PMOD	O
O	O	O	2049	2051	in	in	B-PP	IN	O	36	NMOD	O
O	O	O	2052	2057	shear	shear	B-NP	NN	O	39	NMOD	O
O	O	O	2058	2062	flow	flow	I-NP	NN	O	37	PMOD	O
O	O	O	2063	2066	and	and	O	CC	O	8	DEP	O
O	O	O	2067	2071	thus	thus	B-ADVP	RB	O	40	VMOD	O
O	O	O	2072	2075	for	for	B-PP	IN	O	41	PMOD	O
O	O	O	2076	2084	monocyte	monocyte	B-NP	NN	O	44	NMOD	O
O	O	O	2085	2097	infiltration	infiltration	I-NP	NN	O	42	PMOD	O
O	O	O	2098	2100	in	in	B-PP	IN	O	44	NMOD	O
O	O	O	2101	2116	atherosclerotic	atherosclerotic	B-NP	JJ	O	47	NMOD	O
O	O	O	2117	2124	plaques	plaque	I-NP	NNS	O	45	PMOD	O
O	O	O	2124	2125	.	.	O	.	O	5	P	O
